“Novo Nordisk Stock Jumps As Wegovy Sales Skyrocket 734%, Crushing Expectations”
November 2, 2023
“…For the September quarter, Novo’s sales climbed 29% to 58.73 billion Danish krone, or roughly $8.39 billion, based on today’s exchange rates. That topped the FactSet-polled analyst view for 57.88 billion Danish krone.
Adjusted profit came out 5.02 Danish krone per share — about 72 cents a share. Earnings grew 57% and topped expectations for 4.70 Danish krone.
Sales of weight-loss blockbuster Wegovy skyrocketed 734% to 9.65 Danish krone, or $1.38 billion. That came in well above expectations for 7.72 billion Danish krone…”